Interestingly, in vitro MFE23-4-1BBL and Sm9b-4-1BBL (targeting membrane-distal CEACAM5 epitopes) performed superiorly in binding to tumor cells and in the functional Jurkat-human-4-1BB-NFkB-luc2 reporter cell assay. Here, CEACAM5 is linked to neoplasm.